STAA - スタ―サ―ジカル (STAAR Surgical Company)

STAAのニュース

   STAAR Surgical: Data Approach Justifies Portfolio Allocation  2022/07/05 19:15:51 Seeking Alpha
STAAR Surgical (STAA) presents with the fundamental momentum that we feel can drive equity returns into the coming years. See why we rate STAA stock a buy.
   STAAR Surgical Company (NASDAQ: STAA) Stock Price Forecast: $100  2022/06/25 14:00:00 Stocks Register
STAAR Surgical Company (NASDAQ:STAA) shares, rose in value on Friday, 06/24/22, with the stock price up by 3.72% to the previous day’s close as strong demand from buyers drove the stock to $74.78. Actively observing the price movement in the last trading, the stock closed the session at $72.10, falling within a range of $71.00 … STAAR Surgical Company (NASDAQ: STAA) Stock Price Forecast: $100 Read More »
   STAAR Surgical Celebrates Two Million Lens Milestone for Implantable Collamer Lens (ICL)  2022/06/07 11:00:00 Wallstreet:Online
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that more than two million Visian Implantable Collamer lenses (“ICLs”) have been sold globally, including more than one and a half million of the company’s latest generation of implantable lenses – EVO Visian ICLs (“EVO”).
   STAAR Surgical Celebrates Two Million Lens Milestone for Implantable Collamer® Lens (ICL)  2022/06/07 11:00:00 Business Wire
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that more than two million Visian® Implantable Collamer lenses (“ICLs”) have been sold globally, including more than one and a half million of the company’s latest generation of implantable lenses – EVO Visian® ICLs (“EVO”). New to the U.S. market, EVO is available in more than 75 countries a
   STAAR Surgical Company (NASDAQ: STAA) Stock Gained 12.14% Over A Month – Any Room To Run?  2022/05/28 16:00:00 Marketing Sentinel
STAAR Surgical Company (NASDAQ:STAA)’s traded shares stood at 0.35 million during the last session, with the company’s beta value hitting 1.13. At the close of trading, the stock’s price was $67.04, to imply an increase of 6.65% or $4.18 in intraday trading. The STAA share’s 52-week high remains $163.08, putting it -143.26% down since that … STAAR Surgical Company (NASDAQ: STAA) Stock Gained 12.14% Over A Month – Any Room To Run? Read More »
   Intraocular Lens Market Generated Opportunities, Future Scope 2021-2028 | STAAR Surgical Company, HOYA Corporation, Lenstec, Inc.  2021/12/24 07:53:54 OpenPR
Another factual information on the "Intraocular Lens Market" has as of late added by CMI to its storehouse. This global research report offers an inside and out examination of various perspectives, for example, global market patterns, pieces of the overall
   Stephens Inc. AR Sells 1,712 Shares of STAAR Surgical (NASDAQ:STAA)  2021/12/22 09:40:45 Dakota Financial News
Stephens Inc. AR trimmed its holdings in shares of STAAR Surgical (NASDAQ:STAA) by 23.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,636 shares of the medical instruments suppliers stock after selling 1,712 shares during the period. Stephens Inc. ARs holdings in []
   Strs Ohio Reduces Stake in STAAR Surgical (NASDAQ:STAA)  2021/12/18 10:04:41 Dakota Financial News
Strs Ohio trimmed its stake in STAAR Surgical (NASDAQ:STAA) by 21.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 12,200 shares of the medical instruments suppliers stock after selling 3,400 shares during the quarter. Strs Ohios holdings in STAAR []
   $59.30 Million in Sales Expected for STAAR Surgical (NASDAQ:STAA) This Quarter  2021/12/15 03:16:42 Transcript Daily
Equities analysts expect STAAR Surgical (NASDAQ:STAA) to report sales of $59.30 million for the current quarter, Zacks reports. Three analysts have made estimates for STAAR Surgicals earnings, with estimates ranging from $59.10 million to $59.40 million. STAAR Surgical posted sales of $46.00 million during the same quarter last year, which suggests a positive year-over-year growth []
   STAAR Surgical (NASDAQ:STAA) CTO Keith Holliday Sells 6,000 Shares  2021/12/15 01:50:43 Transcript Daily
STAAR Surgical (NASDAQ:STAA) CTO Keith Holliday sold 6,000 shares of the firms stock in a transaction on Tuesday, December 14th. The shares were sold at an average price of $89.57, for a total transaction of $537,420.00. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Shares of []
   STAAR Surgical Company (NASDAQ: STAA): Aiming For A Higher Share Price  2021/11/06 15:00:00 Stocks Register
STAAR Surgical Company (NASDAQ:STAA) shares, rose in value on Friday, 11/05/21, with the stock price down by -1.31% to the previous days close as strong demand from buyers drove the stock to $115.59. Actively observing the price movement in the last trading, the stock closed the session at $117.12, falling within a range of $109.13 STAAR Surgical Company (NASDAQ: STAA): Aiming For A Higher Share Price Read More »
   STAAR Surgical Company (STAA) Q3 2021 Earnings Call Transcript  2021/11/04 03:31:29 The Motley Fool
STAA earnings call for the period ending September 30, 2021.
   STAAR Surgical EPS beats by $0.04, misses on revenue  2021/11/03 20:04:24 Seeking Alpha
   Zacks: Analysts Expect STAAR Surgical (NASDAQ:STAA) Will Post Earnings of $0.16 Per Share  2021/10/28 07:46:44 Transcript Daily
Wall Street brokerages expect STAAR Surgical (NASDAQ:STAA) to post $0.16 earnings per share for the current fiscal quarter, according to Zacks. Three analysts have issued estimates for STAAR Surgicals earnings, with the lowest EPS estimate coming in at $0.15 and the highest estimate coming in at $0.17. STAAR Surgical posted earnings per share of $0.14 []
   Ocular Implant Market Detailed In New Research Report 2021 | Novartis AG, Pfizer Inc., Staar Surgical, Johnson & Johnson Services  2021/10/28 07:04:46 OpenPR
Ocular implants are medical instruments that are designed to replace a damaged or missing visual organ to restore vision or to improve visual appearance. Ocular implants such as ocular prostheses are artificial eyes used by people to enhance facial lineaments

calendar